Sharon Bio-Medicine informs about outcome of board meeting

13 Aug 2021 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015, Sharon Bio-Medicine has informed that the following documents are enclosed: Un-audited financial results for the quarter ended June 30, 2021; Limited Review Report for the quarter ended June 30, 2021. The said results are being uploaded on the website of the Company, i.e., www.sharonbio.com. The meeting commenced at 2.00 pm and concluded at 4.15 pm.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×